Latham & Watkins LLP
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Latham & Watkins LLP advises industry-leading healthcare and pharmaceutical companies on a complex range of transactions and corporate matters. These include acquisitions of specialised biotech companies and healthcare retailers, medical and pharmaceutical market entries for global clients, and start-up financing rounds and share sales for venture capital and private equity funds. Furthermore, the practice has also acted in regulatory proceedings. Leading a dedicated team that also offers legal expertise in tax, competition, employment and IP law, Henning Schneider is a healthcare and life sciences transactional specialist, and he is joined on a diverse range of corporate law matters by Christoph Engeler and Henrietta Ditzen. Another leading name is Deniz Tschammler, who leads on novel platform and business management establishment matters for life science technology companies.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Deniz Tschammler combines deep regulatory knowledge with commercial pragmatism and helped us think through complex EU AI and medical device regulations to develop an actionable strategy. His counsel is both technically precise and strategically grounded.’
- ‘The LW team is a great resource when it comes to work in the healthcare sector as it is deeply plugged into current developments and regulatory trends. They combine substantial experience from work in the healthcare sector, excellent commercial understanding of value chains besides best in class legal knowledge. The quality of work product is excellent. Personal interaction is highly professional and very collaborative - the team has a great "lets solve the problem" attitude.’
Key clients
- Amalgam Rx
- Cheplapharm
Work highlights
Advised Demant A/S on the €700m acquisition of KIND Group.